Solid growth for LUMIBIRD in the first half of 2026

The LUMIBIRD Group recorded a 7.4% increase in its consolidated revenue, reaching €114.7 million in the first half of 2026. The Photonics division saw a notable increase in revenue of 15.3%, thanks to developments in the Defense & Space and Medtech Photonics sectors.

Defense & Space activities saw a 16.5% increase, highlighting the impact of major ongoing programs. Medtech Photonics stood out with a 58.3% increase, driven by cardiovascular applications.

As for the Medical division, although it suffered some disruptions at the beginning of the year, it regained positive momentum in the second quarter, with an increase of 2.6% on a like-for-like basis.

Geographic performance varied, with the Americas showing the strongest growth in Photonics. LUMIBIRD continues to demonstrate its resilience and long-term growth potential.